CCL23 and COVID-19: In contrast, pro-inflammatory cytokines and chemokines, including CCL14, CCL23, IL7, IL16 and IL18, were preferentially expressed in men, underlying the higher susceptibility of men developing cytokine release syndrome in COVID-19.